Mediamedic/LinkedIn
Oct 4, 2025, 10:05
ISEH 2025 China–Japan Dialogue With Professors Jianxiang Wang and Naoki Hosen
Mediamedic shared a post on LinkedIn:
“ISEH 2025 China–Japan Dialogue | Professors Jianxiang Wang & Naoki Hosen: CAR-T Therapy for Leukemia and Global Collaboration
At the 54th ISEH Annual Scientific Meeting in Kumamoto, Japan, Professor Jianxiang Wang (Institute of Hematology & Blood Diseases Hospital, CAMS) and Professor Naoki Hosen (Osaka University) engaged in a deep dialogue on the future of CAR-T therapy for leukemia.
Their conversation explored basic mechanisms, clinical applications, efficacy optimization, and future directions, highlighting the importance of international collaboration to expand innovation and patient access worldwide.”
Stay updated with Hemostasis Today.
-
Jul 12, 2026, 12:30Reduced-Dose DOACs in GI Malignancies: Toward Personalized Anticoagulation
-
Jul 12, 2026, 08:50Where the Hemophilia Community Comes Together at ISTH 2026 – EAHAD
-
Jul 12, 2026, 08:2210 Posts Not To Miss from ISTH 2026, Part 1
-
Jul 12, 2026, 07:58Brian O Mahony: Could NXT-007 Minimize the Need for Perioperative FVIII
-
Jul 12, 2026, 07:50Shayan Mohammadmoradi: Connecting the Next Generation of Hemostasis Researchers at ISTH 2026
-
Jul 12, 2026, 07:42Alexandra Yakusheva: ThrombInnov Debuts at ISTH 2026 with a Focus on Translational Research
-
Jul 12, 2026, 07:34Wolfgang Miesbach: ISTH 2026 Explores the Next Generation of APS Diagnostics
-
Jul 12, 2026, 07:28Sara Zalghout: ISTH 2026 Highlights Progress in Thromboinflammation Research
-
Jul 12, 2026, 07:13Ekaterina Balaian: Finding Healing Through Art at ISTH 2026